Larry Gold
Concepts (330)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aptamers, Nucleotide | 9 | 2016 | 74 | 2.150 |
Why?
| RNA | 24 | 2020 | 875 | 1.950 |
Why?
| SELEX Aptamer Technique | 7 | 2016 | 14 | 1.400 |
Why?
| Proteomics | 11 | 2014 | 903 | 1.380 |
Why?
| T-Phages | 15 | 1991 | 22 | 1.210 |
Why?
| Nucleic Acid Conformation | 33 | 2000 | 680 | 1.120 |
Why?
| RNA, Catalytic | 4 | 2020 | 183 | 1.110 |
Why?
| Base Sequence | 53 | 2003 | 2207 | 1.090 |
Why?
| Escherichia coli | 23 | 1997 | 766 | 1.040 |
Why?
| Molecular Sequence Data | 53 | 2012 | 2926 | 1.020 |
Why?
| Viral Proteins | 14 | 1997 | 302 | 0.820 |
Why?
| Oligoribonucleotides | 10 | 1997 | 52 | 0.820 |
Why?
| DNA, Single-Stranded | 7 | 2003 | 114 | 0.760 |
Why?
| Ligands | 22 | 2016 | 574 | 0.750 |
Why?
| Biomarkers | 9 | 2015 | 3736 | 0.740 |
Why?
| Ribosomes | 12 | 1995 | 147 | 0.710 |
Why?
| Proteome | 6 | 2014 | 359 | 0.700 |
Why?
| Ribonucleotides | 1 | 2020 | 27 | 0.700 |
Why?
| RNA, Messenger | 15 | 2000 | 2753 | 0.690 |
Why?
| Oligodeoxyribonucleotides | 8 | 2003 | 141 | 0.660 |
Why?
| Reverse Transcriptase Inhibitors | 6 | 1996 | 87 | 0.630 |
Why?
| Proteins | 9 | 2014 | 951 | 0.600 |
Why?
| Genes, Viral | 11 | 1995 | 93 | 0.560 |
Why?
| Peptide Chain Initiation, Translational | 6 | 1995 | 38 | 0.530 |
Why?
| Protein Biosynthesis | 10 | 1997 | 416 | 0.530 |
Why?
| Binding Sites | 23 | 2000 | 1248 | 0.510 |
Why?
| HIV-1 | 8 | 1996 | 787 | 0.490 |
Why?
| Blood Proteins | 3 | 2015 | 253 | 0.490 |
Why?
| RNA, Viral | 10 | 2000 | 587 | 0.480 |
Why?
| Muscular Dystrophy, Duchenne | 1 | 2015 | 80 | 0.470 |
Why?
| Oligonucleotides | 4 | 2011 | 141 | 0.460 |
Why?
| Q beta Replicase | 4 | 1996 | 4 | 0.440 |
Why?
| RNA, Ribosomal | 1 | 2014 | 157 | 0.440 |
Why?
| Diagnosis | 2 | 2013 | 10 | 0.420 |
Why?
| Capsid | 3 | 2000 | 77 | 0.410 |
Why?
| DNA | 4 | 2011 | 1406 | 0.410 |
Why?
| Bacteriophage T4 | 4 | 1997 | 17 | 0.400 |
Why?
| Kinetics | 14 | 2010 | 1680 | 0.350 |
Why?
| Polymerase Chain Reaction | 15 | 2000 | 1042 | 0.350 |
Why?
| Protein Binding | 13 | 2014 | 2014 | 0.350 |
Why?
| Gene Products, rev | 2 | 2002 | 5 | 0.340 |
Why?
| HIV Reverse Transcriptase | 5 | 1996 | 30 | 0.340 |
Why?
| DNA-Directed DNA Polymerase | 3 | 1997 | 45 | 0.320 |
Why?
| History, 20th Century | 3 | 2015 | 290 | 0.310 |
Why?
| Capsid Proteins | 2 | 2000 | 70 | 0.310 |
Why?
| Evolution, Molecular | 4 | 2020 | 458 | 0.310 |
Why?
| Bacterial Proteins | 4 | 1996 | 777 | 0.300 |
Why?
| Information Systems | 3 | 1998 | 67 | 0.300 |
Why?
| RNA, Bacterial | 4 | 2000 | 176 | 0.300 |
Why?
| Biological Evolution | 5 | 2014 | 459 | 0.290 |
Why?
| RNA-Binding Proteins | 4 | 2000 | 394 | 0.280 |
Why?
| RNA, Transfer | 4 | 1991 | 119 | 0.270 |
Why?
| Directed Molecular Evolution | 2 | 1996 | 25 | 0.270 |
Why?
| DNA-Binding Proteins | 5 | 1993 | 1373 | 0.270 |
Why?
| RNA Processing, Post-Transcriptional | 4 | 1996 | 86 | 0.270 |
Why?
| Bacteriophages | 2 | 2000 | 75 | 0.260 |
Why?
| DNA Primers | 10 | 2012 | 545 | 0.260 |
Why?
| RNA-Directed DNA Polymerase | 5 | 1996 | 34 | 0.250 |
Why?
| Protein Array Analysis | 3 | 2014 | 63 | 0.240 |
Why?
| Clinical Laboratory Techniques | 2 | 2003 | 95 | 0.240 |
Why?
| Gene Library | 2 | 2010 | 130 | 0.240 |
Why?
| Cloning, Molecular | 11 | 1998 | 566 | 0.240 |
Why?
| Tenascin | 1 | 2003 | 13 | 0.230 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 785 | 0.220 |
Why?
| Templates, Genetic | 6 | 2003 | 62 | 0.220 |
Why?
| Biomarkers, Tumor | 3 | 2012 | 1080 | 0.210 |
Why?
| Peptide Initiation Factors | 3 | 1993 | 17 | 0.210 |
Why?
| Amino Acid Sequence | 9 | 2003 | 2098 | 0.210 |
Why?
| DNA, Bacterial | 5 | 1997 | 321 | 0.210 |
Why?
| Plasmids | 6 | 1992 | 361 | 0.200 |
Why?
| Codon | 7 | 1994 | 90 | 0.200 |
Why?
| Drug Evaluation, Preclinical | 1 | 2002 | 184 | 0.200 |
Why?
| Protein Interaction Mapping | 1 | 2002 | 107 | 0.190 |
Why?
| Bacteriophage lambda | 3 | 1992 | 81 | 0.190 |
Why?
| Genomic Library | 2 | 2000 | 15 | 0.190 |
Why?
| Combinatorial Chemistry Techniques | 1 | 2000 | 19 | 0.180 |
Why?
| Antibodies | 3 | 2014 | 396 | 0.170 |
Why?
| Aptamers, Peptide | 2 | 2011 | 5 | 0.170 |
Why?
| Genome, Bacterial | 1 | 2000 | 111 | 0.170 |
Why?
| Substrate Specificity | 6 | 2000 | 381 | 0.170 |
Why?
| Neoplasm Proteins | 1 | 2003 | 409 | 0.170 |
Why?
| Gene Expression Regulation | 6 | 2002 | 2492 | 0.170 |
Why?
| Structure-Activity Relationship | 7 | 2002 | 533 | 0.160 |
Why?
| Nucleic Acids | 2 | 2011 | 61 | 0.160 |
Why?
| Antiviral Agents | 2 | 1995 | 673 | 0.150 |
Why?
| Recombinant Proteins | 7 | 2014 | 1327 | 0.150 |
Why?
| Mass Spectrometry | 4 | 2010 | 699 | 0.150 |
Why?
| Humans | 28 | 2016 | 125131 | 0.150 |
Why?
| Computer Simulation | 3 | 1998 | 953 | 0.150 |
Why?
| Chloramphenicol | 1 | 1997 | 6 | 0.150 |
Why?
| Peptidyl Transferases | 1 | 1997 | 7 | 0.150 |
Why?
| Erythrocyte Membrane | 1 | 1998 | 52 | 0.150 |
Why?
| Ribosomal Proteins | 2 | 1995 | 72 | 0.150 |
Why?
| DNA, Viral | 4 | 1993 | 360 | 0.140 |
Why?
| Reproducibility of Results | 4 | 2011 | 3047 | 0.140 |
Why?
| S-Adenosylmethionine | 1 | 1997 | 54 | 0.140 |
Why?
| Binding, Competitive | 5 | 1996 | 209 | 0.140 |
Why?
| Guanosine Monophosphate | 1 | 1996 | 7 | 0.140 |
Why?
| Gene Products, gag | 1 | 1996 | 37 | 0.140 |
Why?
| Repressor Proteins | 3 | 1996 | 383 | 0.140 |
Why?
| Models, Molecular | 4 | 2012 | 1450 | 0.140 |
Why?
| Molecular Biology | 1 | 1997 | 58 | 0.140 |
Why?
| Bradykinin | 1 | 1996 | 48 | 0.140 |
Why?
| Nucleic Acid Hybridization | 2 | 2010 | 196 | 0.130 |
Why?
| DNA Replication | 3 | 1993 | 218 | 0.130 |
Why?
| DNA Nucleotidyltransferases | 1 | 1995 | 11 | 0.130 |
Why?
| Base Composition | 4 | 1996 | 79 | 0.130 |
Why?
| RNA, Antisense | 2 | 1992 | 20 | 0.130 |
Why?
| Endoribonucleases | 1 | 1996 | 74 | 0.130 |
Why?
| Adenosine | 1 | 1997 | 215 | 0.130 |
Why?
| Nerve Growth Factors | 1 | 1995 | 73 | 0.130 |
Why?
| Substance P | 1 | 1995 | 44 | 0.120 |
Why?
| Eye Diseases | 1 | 2016 | 78 | 0.120 |
Why?
| Ribonucleases | 1 | 1994 | 55 | 0.120 |
Why?
| Transcription, Genetic | 5 | 2000 | 1376 | 0.120 |
Why?
| Ophthalmology | 1 | 2016 | 78 | 0.120 |
Why?
| Consensus Sequence | 5 | 2000 | 71 | 0.120 |
Why?
| RNA, Transfer, Amino Acid-Specific | 1 | 1994 | 4 | 0.120 |
Why?
| Selenocysteine | 1 | 1994 | 3 | 0.120 |
Why?
| RNA, Transfer, Amino Acyl | 1 | 1994 | 7 | 0.120 |
Why?
| Origin of Life | 1 | 2014 | 10 | 0.120 |
Why?
| Hydrolysis | 4 | 1997 | 186 | 0.120 |
Why?
| Escherichia coli Proteins | 1 | 1996 | 176 | 0.120 |
Why?
| Peptide Elongation Factors | 1 | 1994 | 14 | 0.120 |
Why?
| Models, Theoretical | 1 | 1998 | 585 | 0.110 |
Why?
| Enzyme Inhibitors | 1 | 1997 | 841 | 0.110 |
Why?
| Genetic Techniques | 2 | 2010 | 60 | 0.110 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2010 | 837 | 0.110 |
Why?
| Genetic Vectors | 2 | 1992 | 315 | 0.110 |
Why?
| Catalysis | 3 | 2002 | 298 | 0.110 |
Why?
| Operator Regions, Genetic | 2 | 1990 | 6 | 0.110 |
Why?
| Sensitivity and Specificity | 4 | 2010 | 1885 | 0.110 |
Why?
| History, 21st Century | 1 | 2014 | 181 | 0.110 |
Why?
| Carcinoma, Non-Small-Cell Lung | 2 | 2012 | 985 | 0.110 |
Why?
| Proto-Oncogene Proteins c-sis | 1 | 2012 | 35 | 0.110 |
Why?
| Models, Genetic | 3 | 1991 | 607 | 0.110 |
Why?
| Drug Therapy | 1 | 2013 | 78 | 0.100 |
Why?
| Genes, pX | 1 | 1992 | 2 | 0.100 |
Why?
| Case-Control Studies | 3 | 2015 | 3326 | 0.100 |
Why?
| Deoxyribonuclease EcoRI | 1 | 1992 | 5 | 0.100 |
Why?
| Body Fluids | 1 | 2012 | 65 | 0.100 |
Why?
| Affinity Labels | 2 | 2014 | 27 | 0.100 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 181 | 0.100 |
Why?
| Mutation | 7 | 1995 | 3520 | 0.100 |
Why?
| Electrophoresis, Polyacrylamide Gel | 4 | 1993 | 340 | 0.100 |
Why?
| Diagnostic Techniques and Procedures | 1 | 2011 | 17 | 0.100 |
Why?
| DNA Transposable Elements | 1 | 1992 | 101 | 0.100 |
Why?
| RNA, Ribosomal, 16S | 1 | 1993 | 524 | 0.090 |
Why?
| Sequence Homology, Nucleic Acid | 4 | 1995 | 159 | 0.090 |
Why?
| Ribonucleotide Reductases | 1 | 1991 | 30 | 0.090 |
Why?
| Chromosome Deletion | 1 | 1991 | 98 | 0.090 |
Why?
| Biological Assay | 1 | 2011 | 123 | 0.090 |
Why?
| Transcription Factors | 2 | 1989 | 1604 | 0.090 |
Why?
| Introns | 1 | 1991 | 241 | 0.090 |
Why?
| Animals | 7 | 2014 | 34345 | 0.090 |
Why?
| Anti-HIV Agents | 1 | 1996 | 701 | 0.090 |
Why?
| Neoplasms | 2 | 2012 | 2340 | 0.090 |
Why?
| Micrococcal Nuclease | 1 | 1989 | 19 | 0.090 |
Why?
| Promoter Regions, Genetic | 3 | 1991 | 1195 | 0.090 |
Why?
| Genes, Regulator | 1 | 1989 | 35 | 0.090 |
Why?
| Databases, Protein | 1 | 2009 | 61 | 0.080 |
Why?
| Exodeoxyribonucleases | 1 | 1988 | 24 | 0.080 |
Why?
| Lung Neoplasms | 2 | 2012 | 2244 | 0.080 |
Why?
| Metalloproteins | 1 | 1987 | 5 | 0.080 |
Why?
| Trans-Activators | 1 | 1990 | 383 | 0.070 |
Why?
| Computational Biology | 2 | 2003 | 616 | 0.070 |
Why?
| Cohort Studies | 2 | 2015 | 5348 | 0.070 |
Why?
| Glomerular Filtration Rate | 1 | 2010 | 709 | 0.070 |
Why?
| Avian Myeloblastosis Virus | 3 | 1996 | 4 | 0.070 |
Why?
| Societies | 1 | 2007 | 42 | 0.070 |
Why?
| Early Detection of Cancer | 1 | 2010 | 364 | 0.070 |
Why?
| Hydrogen-Ion Concentration | 3 | 2004 | 562 | 0.070 |
Why?
| Genes, Bacterial | 2 | 2000 | 163 | 0.070 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 1196 | 0.070 |
Why?
| Oligonucleotide Probes | 3 | 1991 | 55 | 0.070 |
Why?
| Sequence Analysis | 2 | 1996 | 38 | 0.070 |
Why?
| Evidence-Based Medicine | 1 | 2010 | 745 | 0.070 |
Why?
| Conserved Sequence | 2 | 1997 | 222 | 0.070 |
Why?
| Peptide Fragments | 2 | 2003 | 713 | 0.070 |
Why?
| Kidney Failure, Chronic | 1 | 2010 | 523 | 0.060 |
Why?
| Mathematics | 2 | 1998 | 105 | 0.060 |
Why?
| Zinc | 1 | 1987 | 269 | 0.060 |
Why?
| Membrane Proteins | 2 | 2003 | 1089 | 0.060 |
Why?
| Macromolecular Substances | 2 | 1996 | 207 | 0.060 |
Why?
| DNA, Fungal | 2 | 1997 | 70 | 0.060 |
Why?
| Models, Biological | 1 | 1991 | 1753 | 0.060 |
Why?
| RNA, Transfer, Met | 2 | 1994 | 7 | 0.060 |
Why?
| Hydrogen Bonding | 2 | 1994 | 150 | 0.060 |
Why?
| United States | 2 | 2015 | 13613 | 0.060 |
Why?
| Selection, Genetic | 2 | 1998 | 256 | 0.060 |
Why?
| Molecular Structure | 2 | 2012 | 470 | 0.060 |
Why?
| beta-Galactosidase | 3 | 1994 | 72 | 0.060 |
Why?
| Restriction Mapping | 2 | 1995 | 82 | 0.060 |
Why?
| Human Genome Project | 1 | 2003 | 16 | 0.050 |
Why?
| Drug Design | 2 | 1995 | 162 | 0.050 |
Why?
| Isomerism | 2 | 1992 | 51 | 0.050 |
Why?
| Ultraviolet Rays | 2 | 1996 | 417 | 0.050 |
Why?
| Education, Continuing | 1 | 2003 | 42 | 0.050 |
Why?
| Adenosine Triphosphate | 2 | 1997 | 459 | 0.050 |
Why?
| Chromatography, Liquid | 1 | 2003 | 363 | 0.050 |
Why?
| Gene Expression | 3 | 1992 | 1528 | 0.050 |
Why?
| Tumor Cells, Cultured | 1 | 2003 | 902 | 0.050 |
Why?
| Molecular Diagnostic Techniques | 2 | 2014 | 94 | 0.050 |
Why?
| Sequence Analysis, DNA | 2 | 2012 | 767 | 0.050 |
Why?
| Child, Preschool | 1 | 2015 | 9938 | 0.050 |
Why?
| Glioblastoma | 1 | 2003 | 263 | 0.050 |
Why?
| Cross-Linking Reagents | 2 | 2004 | 184 | 0.050 |
Why?
| RNA, Fungal | 2 | 1991 | 69 | 0.050 |
Why?
| Prokaryotic Initiation Factor-3 | 2 | 1990 | 6 | 0.040 |
Why?
| Genome | 1 | 2002 | 290 | 0.040 |
Why?
| Saccharomyces cerevisiae | 2 | 1997 | 511 | 0.040 |
Why?
| In Vitro Techniques | 2 | 1995 | 1144 | 0.040 |
Why?
| Artifacts | 1 | 2000 | 131 | 0.040 |
Why?
| Young Adult | 1 | 2015 | 11384 | 0.040 |
Why?
| Male | 3 | 2015 | 60792 | 0.040 |
Why?
| RNA, Ribosomal, 23S | 1 | 1997 | 12 | 0.040 |
Why?
| DNA Mutational Analysis | 2 | 1990 | 394 | 0.040 |
Why?
| Genomics | 1 | 2003 | 726 | 0.040 |
Why?
| International Cooperation | 2 | 2009 | 187 | 0.040 |
Why?
| gag Gene Products, Human Immunodeficiency Virus | 1 | 1996 | 12 | 0.040 |
Why?
| Peptide Elongation Factor Tu | 1 | 1996 | 5 | 0.040 |
Why?
| Uridine Triphosphate | 1 | 1996 | 11 | 0.040 |
Why?
| Butanones | 1 | 1996 | 3 | 0.040 |
Why?
| Alkylation | 1 | 1996 | 19 | 0.030 |
Why?
| Thionucleotides | 1 | 1996 | 34 | 0.030 |
Why?
| Replicon | 1 | 1996 | 15 | 0.030 |
Why?
| NAD | 1 | 1997 | 73 | 0.030 |
Why?
| Metals | 1 | 1997 | 116 | 0.030 |
Why?
| Adolescent | 1 | 2015 | 19411 | 0.030 |
Why?
| Sulfur | 1 | 1996 | 47 | 0.030 |
Why?
| Gene Dosage | 1 | 1997 | 136 | 0.030 |
Why?
| Neoplasm Metastasis | 2 | 2012 | 573 | 0.030 |
Why?
| rev Gene Products, Human Immunodeficiency Virus | 1 | 1995 | 5 | 0.030 |
Why?
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1995 | 10 | 0.030 |
Why?
| Immunodeficiency Virus, Feline | 1 | 1996 | 30 | 0.030 |
Why?
| Child | 1 | 2015 | 20014 | 0.030 |
Why?
| Buffers | 1 | 1995 | 56 | 0.030 |
Why?
| Aged | 2 | 2012 | 20859 | 0.030 |
Why?
| Aldehydes | 1 | 1996 | 173 | 0.030 |
Why?
| Viral Structural Proteins | 1 | 1995 | 12 | 0.030 |
Why?
| Mammary Tumor Virus, Mouse | 1 | 1995 | 44 | 0.030 |
Why?
| Viruses | 1 | 1996 | 97 | 0.030 |
Why?
| Arginine | 1 | 1996 | 257 | 0.030 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 1997 | 532 | 0.030 |
Why?
| Sepharose | 1 | 1995 | 33 | 0.030 |
Why?
| Virus Integration | 1 | 1995 | 72 | 0.030 |
Why?
| Enzyme Induction | 1 | 1994 | 95 | 0.030 |
Why?
| Ribonuclease H | 1 | 1994 | 13 | 0.030 |
Why?
| Leukemia Virus, Murine | 1 | 1994 | 16 | 0.030 |
Why?
| Sodium Chloride | 1 | 1995 | 154 | 0.030 |
Why?
| Integrases | 1 | 1995 | 125 | 0.030 |
Why?
| Peptide Chain Elongation, Translational | 1 | 1994 | 17 | 0.030 |
Why?
| Selenoproteins | 1 | 1994 | 8 | 0.030 |
Why?
| RNA, Transfer, Phe | 1 | 1993 | 10 | 0.030 |
Why?
| DNA, Complementary | 1 | 1994 | 276 | 0.030 |
Why?
| Models, Structural | 1 | 1993 | 38 | 0.030 |
Why?
| Middle Aged | 2 | 2012 | 29112 | 0.030 |
Why?
| Software | 1 | 1998 | 647 | 0.030 |
Why?
| Adult | 1 | 2015 | 33167 | 0.030 |
Why?
| Rho Factor | 1 | 1993 | 2 | 0.030 |
Why?
| Electrophoresis | 1 | 1992 | 26 | 0.030 |
Why?
| Chromatography, Affinity | 1 | 1993 | 91 | 0.030 |
Why?
| Transition Temperature | 1 | 2012 | 28 | 0.030 |
Why?
| Allosteric Regulation | 1 | 1992 | 87 | 0.030 |
Why?
| Mutagenesis, Site-Directed | 1 | 1993 | 369 | 0.030 |
Why?
| RNA, Small Untranslated | 1 | 2012 | 17 | 0.030 |
Why?
| Complement Inactivating Agents | 1 | 2013 | 43 | 0.030 |
Why?
| Lac Operon | 1 | 1992 | 47 | 0.030 |
Why?
| Amino Acid Motifs | 1 | 2012 | 205 | 0.030 |
Why?
| Titrimetry | 1 | 2011 | 9 | 0.020 |
Why?
| Random Allocation | 1 | 1992 | 377 | 0.020 |
Why?
| Limit of Detection | 1 | 2011 | 59 | 0.020 |
Why?
| Ion Channels | 1 | 1992 | 128 | 0.020 |
Why?
| Automation | 1 | 2011 | 80 | 0.020 |
Why?
| Sequence Analysis, RNA | 1 | 1994 | 423 | 0.020 |
Why?
| Alkaline Phosphatase | 1 | 1992 | 160 | 0.020 |
Why?
| Anticodon | 1 | 1991 | 21 | 0.020 |
Why?
| Crystallography, X-Ray | 1 | 2012 | 432 | 0.020 |
Why?
| Nanotechnology | 1 | 2012 | 121 | 0.020 |
Why?
| Placenta | 1 | 1997 | 649 | 0.020 |
Why?
| Endodeoxyribonucleases | 1 | 1991 | 60 | 0.020 |
Why?
| Triticum | 1 | 1990 | 11 | 0.020 |
Why?
| Neoplasm Invasiveness | 1 | 2012 | 472 | 0.020 |
Why?
| Recombination, Genetic | 1 | 1991 | 176 | 0.020 |
Why?
| Sequence Alignment | 1 | 1991 | 338 | 0.020 |
Why?
| Germany | 1 | 1990 | 90 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 1992 | 344 | 0.020 |
Why?
| Gene Expression Regulation, Viral | 1 | 1990 | 85 | 0.020 |
Why?
| Neovascularization, Pathologic | 1 | 2012 | 287 | 0.020 |
Why?
| Databases, Factual | 1 | 1995 | 1298 | 0.020 |
Why?
| Tetrahydrofolate Dehydrogenase | 1 | 1989 | 14 | 0.020 |
Why?
| Complement System Proteins | 1 | 2013 | 295 | 0.020 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 1989 | 82 | 0.020 |
Why?
| Nervous System Diseases | 1 | 2012 | 267 | 0.020 |
Why?
| Database Management Systems | 1 | 2009 | 58 | 0.020 |
Why?
| Open Reading Frames | 1 | 1989 | 125 | 0.020 |
Why?
| Recombinant Fusion Proteins | 1 | 1992 | 658 | 0.020 |
Why?
| Exodeoxyribonuclease V | 1 | 1988 | 8 | 0.020 |
Why?
| Genes | 1 | 1988 | 237 | 0.020 |
Why?
| Phosphorylation | 1 | 2012 | 1694 | 0.020 |
Why?
| Genetic Complementation Test | 1 | 1987 | 63 | 0.020 |
Why?
| RNA Caps | 1 | 1988 | 34 | 0.020 |
Why?
| Terminology as Topic | 1 | 2009 | 221 | 0.020 |
Why?
| Gene Conversion | 1 | 1987 | 7 | 0.020 |
Why?
| Female | 2 | 2012 | 64889 | 0.020 |
Why?
| Models, Statistical | 1 | 2010 | 664 | 0.020 |
Why?
| Europe | 1 | 2007 | 369 | 0.020 |
Why?
| Virus Replication | 1 | 1987 | 408 | 0.020 |
Why?
| Genetic Variation | 1 | 2010 | 970 | 0.020 |
Why?
| Antibodies, Monoclonal | 1 | 1991 | 1300 | 0.010 |
Why?
| Endostatins | 1 | 2004 | 12 | 0.010 |
Why?
| Interleukin-16 | 1 | 2004 | 7 | 0.010 |
Why?
| Lod Score | 1 | 2004 | 76 | 0.010 |
Why?
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2004 | 25 | 0.010 |
Why?
| Fibroblast Growth Factor 2 | 1 | 2004 | 90 | 0.010 |
Why?
| Carrier Proteins | 1 | 1987 | 743 | 0.010 |
Why?
| Algorithms | 1 | 2010 | 1618 | 0.010 |
Why?
| Autoantibodies | 1 | 2010 | 1382 | 0.010 |
Why?
| Smoking | 1 | 2010 | 1635 | 0.010 |
Why?
| Apoptosis | 1 | 2012 | 2553 | 0.010 |
Why?
| Colonic Neoplasms | 1 | 2004 | 230 | 0.010 |
Why?
| Light | 1 | 2004 | 346 | 0.010 |
Why?
| Inflammation | 1 | 2012 | 2612 | 0.010 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2004 | 537 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2004 | 2026 | 0.010 |
Why?
| Moloney murine leukemia virus | 1 | 1996 | 11 | 0.010 |
Why?
| Zidovudine | 1 | 1996 | 78 | 0.010 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 106 | 0.010 |
Why?
| Cats | 1 | 1996 | 208 | 0.010 |
Why?
| Virion | 1 | 1996 | 78 | 0.010 |
Why?
|
|
Gold's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|